Jonathan Stuart Kaplan
Examiner (ID: 15168)
Most Active Art Unit | 2836 |
Art Unit(s) | 2107, 2104, 2836 |
Total Applications | 226 |
Issued Applications | 203 |
Pending Applications | 10 |
Abandoned Applications | 13 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 8397944
[patent_doc_number] => 08268323
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-18
[patent_title] => 'Conformationally stabilized HIV envelope immunogens'
[patent_app_type] => utility
[patent_app_number] => 13/232775
[patent_app_country] => US
[patent_app_date] => 2011-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 114344
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13232775
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/232775 | Conformationally stabilized HIV envelope immunogens | Sep 13, 2011 | Issued |
Array
(
[id] => 8305710
[patent_doc_number] => 08227243
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-24
[patent_title] => 'Settings for recombinant adenoviral-based vaccines'
[patent_app_type] => utility
[patent_app_number] => 13/199285
[patent_app_country] => US
[patent_app_date] => 2011-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 18776
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13199285
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/199285 | Settings for recombinant adenoviral-based vaccines | Aug 22, 2011 | Issued |
Array
(
[id] => 7656395
[patent_doc_number] => 20110305664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-15
[patent_title] => 'NOVEL VACCINES AGAINST MULTIPLE SUBTYPES OF INFLUENZA VIRUS'
[patent_app_type] => utility
[patent_app_number] => 13/158150
[patent_app_country] => US
[patent_app_date] => 2011-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13988
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20110305664.pdf
[firstpage_image] =>[orig_patent_app_number] => 13158150
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/158150 | Vaccines against multiple subtypes of influenza virus | Jun 9, 2011 | Issued |
Array
(
[id] => 7579850
[patent_doc_number] => 20110293733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-01
[patent_title] => 'SELF-ASSEMBLING NANOPARTICLE DRUG DELIVERY SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 13/085892
[patent_app_country] => US
[patent_app_date] => 2011-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9313
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20110293733.pdf
[firstpage_image] =>[orig_patent_app_number] => 13085892
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/085892 | SELF-ASSEMBLING NANOPARTICLE DRUG DELIVERY SYSTEM | Apr 12, 2011 | Abandoned |
Array
(
[id] => 6174512
[patent_doc_number] => 20110177124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'CODON-OPTIMIZED POLYNUCLEOTIDE-BASED VACCINES AGAINST HUMAN CYTOMEGALOVIRUS INFECTION'
[patent_app_type] => utility
[patent_app_number] => 13/013752
[patent_app_country] => US
[patent_app_date] => 2011-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 37673
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20110177124.pdf
[firstpage_image] =>[orig_patent_app_number] => 13013752
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/013752 | Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection | Jan 24, 2011 | Issued |
Array
(
[id] => 6144401
[patent_doc_number] => 20110130301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'Settings for recombinant adenoviral-based vaccines'
[patent_app_type] => utility
[patent_app_number] => 12/930661
[patent_app_country] => US
[patent_app_date] => 2011-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 18891
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20110130301.pdf
[firstpage_image] =>[orig_patent_app_number] => 12930661
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/930661 | Settings for recombinant adenoviral-based vaccines | Jan 11, 2011 | Issued |
Array
(
[id] => 5943497
[patent_doc_number] => 20110104117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'METABOLICALLY ACTIVATED RECOMBINANT VIRAL VECTORS AND METHODS FOR THEIR PREPARATION AND USE'
[patent_app_type] => utility
[patent_app_number] => 12/910711
[patent_app_country] => US
[patent_app_date] => 2010-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 21735
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20110104117.pdf
[firstpage_image] =>[orig_patent_app_number] => 12910711
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/910711 | Metabolically activated recombinant viral vectors and methods for their preparation and use | Oct 21, 2010 | Issued |
Array
(
[id] => 6615997
[patent_doc_number] => 20100323952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-23
[patent_title] => 'Nucleoside Analogs in Combination Therapy of Herpes Simplex Infections'
[patent_app_type] => utility
[patent_app_number] => 12/871563
[patent_app_country] => US
[patent_app_date] => 2010-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2099
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0323/20100323952.pdf
[firstpage_image] =>[orig_patent_app_number] => 12871563
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/871563 | Nucleoside Analogs in Combination Therapy of Herpes Simplex Infections | Aug 29, 2010 | Abandoned |
Array
(
[id] => 8328462
[patent_doc_number] => 08236558
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-07
[patent_title] => 'Bovine immunodeficiency virus (BIV) based vectors'
[patent_app_type] => utility
[patent_app_number] => 12/871902
[patent_app_country] => US
[patent_app_date] => 2010-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17441
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12871902
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/871902 | Bovine immunodeficiency virus (BIV) based vectors | Aug 29, 2010 | Issued |
Array
(
[id] => 7977981
[patent_doc_number] => 08071738
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-06
[patent_title] => 'Feline CD86 polypeptides and nucleic acids'
[patent_app_type] => utility
[patent_app_number] => 12/794422
[patent_app_country] => US
[patent_app_date] => 2010-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 40067
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/071/08071738.pdf
[firstpage_image] =>[orig_patent_app_number] => 12794422
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/794422 | Feline CD86 polypeptides and nucleic acids | Jun 3, 2010 | Issued |
Array
(
[id] => 7773538
[patent_doc_number] => 08119339
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-21
[patent_title] => 'Heteroduplex tracking assay'
[patent_app_type] => utility
[patent_app_number] => 12/723162
[patent_app_country] => US
[patent_app_date] => 2010-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 35836
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/119/08119339.pdf
[firstpage_image] =>[orig_patent_app_number] => 12723162
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/723162 | Heteroduplex tracking assay | Mar 11, 2010 | Issued |
Array
(
[id] => 5958551
[patent_doc_number] => 20110182938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'INFLUENZA NUCLEIC ACID MOLECULES AND VACCINES MADE THEREFROM'
[patent_app_type] => utility
[patent_app_number] => 12/694238
[patent_app_country] => US
[patent_app_date] => 2010-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16908
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20110182938.pdf
[firstpage_image] =>[orig_patent_app_number] => 12694238
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/694238 | Influenza nucleic acid molecules and vaccines made therefrom | Jan 25, 2010 | Issued |
Array
(
[id] => 5958551
[patent_doc_number] => 20110182938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'INFLUENZA NUCLEIC ACID MOLECULES AND VACCINES MADE THEREFROM'
[patent_app_type] => utility
[patent_app_number] => 12/694238
[patent_app_country] => US
[patent_app_date] => 2010-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16908
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20110182938.pdf
[firstpage_image] =>[orig_patent_app_number] => 12694238
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/694238 | Influenza nucleic acid molecules and vaccines made therefrom | Jan 25, 2010 | Issued |
Array
(
[id] => 6575825
[patent_doc_number] => 20100129438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'Methods and Compositions for the Treatment and Prevention of HIV Infection Using TRIM5ALPHA'
[patent_app_type] => utility
[patent_app_number] => 12/689800
[patent_app_country] => US
[patent_app_date] => 2010-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 48217
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20100129438.pdf
[firstpage_image] =>[orig_patent_app_number] => 12689800
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/689800 | Methods and compositions for the treatment and prevention of HIV infection using TRIM5α | Jan 18, 2010 | Issued |
Array
(
[id] => 6608567
[patent_doc_number] => 20100099188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'Dual Inhibitors of HIV-1 gp-120 Interactions'
[patent_app_type] => utility
[patent_app_number] => 12/638725
[patent_app_country] => US
[patent_app_date] => 2009-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 1701
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20100099188.pdf
[firstpage_image] =>[orig_patent_app_number] => 12638725
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/638725 | Dual inhibitors of HIV-1 gp-120 interactions | Dec 14, 2009 | Issued |
Array
(
[id] => 6529181
[patent_doc_number] => 20100015176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'Settings for recombinant adenoviral-based vaccines'
[patent_app_type] => utility
[patent_app_number] => 12/583628
[patent_app_country] => US
[patent_app_date] => 2009-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 18938
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20100015176.pdf
[firstpage_image] =>[orig_patent_app_number] => 12583628
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/583628 | Settings for recombinant adenoviral-based vaccines | Aug 23, 2009 | Issued |
Array
(
[id] => 6280571
[patent_doc_number] => 20100119536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'Naturally Processed Measles Virus Peptides From Class II HLA Molecules'
[patent_app_type] => utility
[patent_app_number] => 12/507163
[patent_app_country] => US
[patent_app_date] => 2009-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 27514
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20100119536.pdf
[firstpage_image] =>[orig_patent_app_number] => 12507163
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/507163 | Naturally processed measles virus peptides from class II HLA molecules | Jul 21, 2009 | Issued |
Array
(
[id] => 4555439
[patent_doc_number] => 07842298
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-30
[patent_title] => 'Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E'
[patent_app_type] => utility
[patent_app_number] => 12/507576
[patent_app_country] => US
[patent_app_date] => 2009-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 42
[patent_no_of_words] => 20651
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/842/07842298.pdf
[firstpage_image] =>[orig_patent_app_number] => 12507576
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/507576 | Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E | Jul 21, 2009 | Issued |
Array
(
[id] => 6535482
[patent_doc_number] => 20100015596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'RS VIRUS DETECTING KIT USING ANTI-RS VIRUS MONOCLONAL ANTIBODY, IMMUNO-CHROMATOGRAPHIC TEST DEVICE, AND NEW ANTI-RS VIRUS MONOCLONAL ANTIBODY'
[patent_app_type] => utility
[patent_app_number] => 12/505144
[patent_app_country] => US
[patent_app_date] => 2009-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9715
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20100015596.pdf
[firstpage_image] =>[orig_patent_app_number] => 12505144
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/505144 | RS VIRUS DETECTING KIT USING ANTI-RS VIRUS MONOCLONAL ANTIBODY, IMMUNO-CHROMATOGRAPHIC TEST DEVICE, AND NEW ANTI-RS VIRUS MONOCLONAL ANTIBODY | Jul 16, 2009 | Abandoned |
Array
(
[id] => 6485430
[patent_doc_number] => 20100285457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'High-Throughput Diagnostic Assay For the Human Virus Causing Severe Acute Respiratory Syndrome (SARS)'
[patent_app_type] => utility
[patent_app_number] => 12/483301
[patent_app_country] => US
[patent_app_date] => 2009-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 111
[patent_figures_cnt] => 111
[patent_no_of_words] => 33933
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12483301
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/483301 | High-Throughput Diagnostic Assay For the Human Virus Causing Severe Acute Respiratory Syndrome (SARS) | Jun 11, 2009 | Abandoned |